Drug intelligence / Profile preview

polymerized alternaria alternata allergen extract

Development stage
Unknown
Lead developer
Inmunotek
Modality
Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Vaccines & Immunotherapeutics
Administration
Subcutaneous
01

Overview

Polymerized Alternaria alternata allergen extract is a chemically modified allergen extract (allergoid) derived from the fungus Alternaria alternata, intended for use in allergen-specific immunotherapy. The extract is prepared by depigmenting, then chemically polymerizing native Alternaria allergens with glutaraldehyde, resulting in high-molecular-mass complexes with reduced IgE-binding activity while retaining immunogenicity. Major allergens in the polymer include Alt a 1, Alt a 3, Alt a 6, and Alt a 8. This modification aims to reduce the risk of adverse reactions (notably, less IgE-mediated reactivity) compared to native extracts, while still promoting the induction of protective IgG antibodies capable of blocking allergen–IgE interactions. Polymerized extracts demonstrate strong potential for safer and effective immunotherapy in both adults and children with allergies to Alternaria alternata, and are especially suitable for those with polysensitization, as the reduced enzymatic/proteolytic activity decreases degradation of other combined allergens in mixed formulations. The immunological mechanism chiefly involves immune modulation (regulatory T cell and Th1 response, increased IL-10, suppressed Th2 reactivity), resulting in increased tolerance to Alternaria antigens.

Other names
polymerized alternaria allergoidpolymerized alternaria alternata extractalternaria depigmented-polymerized extractADPglutaraldehyde-polymerized alternaria alternata extractalternaria allergoid
02

Targets

A. annua-specific IgE (Artemisia annua-specific immunoglobulin E)

Beyond the preview

Go deeper on polymerized alternaria alternata allergen extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polymerized alternaria alternata allergen extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call